Company Overview and News
Updater Inc (ASX:UPD) has confirmed a market penetration of 16.59% of all U.S. household moves in Q3, an increase of 42% over Q2, in the self-executed (do it yourself) moving vertical.
Updater Inc (ASX:UPD) is starting a 9-month pilot program with AT&T Inc (NYSE:T) to test various communication strategies with consumers who are moving.
Updater Inc (ASX:UPD) has received commitments to raise $30 million via a private placement of CHESS Depositary Interests (CDI) at $0.50 per CDI. The company received the support of Fidelity International, one of the world’s preeminent investors, along with Thorney Investment Group and other existing institutional shareholders. The proceeds from the placement will be used to accelerate growth, as Updater plans to expand its sales, client support, product and engineering teams.
Updater Inc Ltd (ASX:UPD) has been granted a trading halt by the ASX this morning, pending details of a capital raising. The halt will remain in place until the opening of trade on Wednesday 28th September 2016, or earlier if an announcement is made to the market.
Updater Inc’s (ASX:UPD) pilot programs with Liberty Mutual and also with other moving companies will both launch ahead of schedule, aiming to prove the value of the Updater platform. Founded in 2010 and seeded by Australian investors, Updater is headquartered in New York City and develops technology to improve the consumer relocation process in the U.S. The company has developed a centralised tool that is used by people who move houses to manage services such as mail forwarding, transferring utilities and updating addresses.
Updater Inc (ASX:UPD) is continuing the trend of significant growth by processing 79,781 unique household moves in July, equating to an estimated market share of 5.35% of all household moves in the U.S. Updater’s market share has climbed to 5.35%. The company has built a centralised tool that is used by people who move houses to manage services such as mail forwarding, transferring utilities and updating addresses.
Updater Inc (ASX:UPD) has processed nearly 90,000 unique household moves in June, equating to an estimated market share of 4.74% of all household moves in the United States. The company’s volumes have grown significantly by processing 89,347 moves in June, a 39% increase compared to 64,284 moves in May. Updater’s centralised tool is used by people who move houses to manage services such as mail forwarding, transferring utilities and updating addresses.
New York based Updater Inc (ASX:UPD) has signed a business product pilot with Liberty Mutual Insurance, integrating Updater’s relocation technology platform for its customers. Updater’s technology has garnered a share of U.S. household moves, by providing a centralised tool for people to manage services such as mail forwarding, transferring utilities and updating addresses. The pilot with Liberty Mutual will last for 12 months and is structured as an iterative and collaborative partnership to test various communication strategies with movers.
2018-04-25 - Asif
Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...
2018-04-25 - Asif
Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...
2018-04-23 - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...